Astrocytoma, IDH-Mutant, Grade 4 — Trials

Astrocytoma, IDH-Mutant, Grade 4 — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 8%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07673679	GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4(GliomaAI-A4)	completed	—	1,372	Deep Learning Institute of Radiological SciencesOTHER	1	Jun 29, 2026	clinicaltrials
NCT05375318	BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels(BIOhabitats)	completed	—	50	Juan M Garcia-Gomez